Más Dermatol. 2022;Suppl 1:S4-S12 doi:10.5538/1887-5181.2022.S1.S4 12 Nueva tecnología de liberación transungueal: CicloTech® Otero FJ, et al. BIBLIOGRAFÍA 1. Cutrín-Gómez E. Lacas para el tratamiento de onicomicosis y psoriasis ungueal [tesis doctoral]. Santiago de Compostela: Centro Internacional de Estudios de Doutoramento e Avanzados da USC (CIEDUS); 2017. 2. Cutrín-Gómez E, Conde-Penedo A, Anguiano-Igea S, GómezAmoza JL, Otero-Espinar FJ. Optimization of drug permeation from 8% ciclopirox cyclodextrin/poloxamer-soluble polypseudorotaxane-based nail lacquers. Pharmaceutics. 2020;12(3):231. 3. Nogueiras-Nieto L, Álvarez-Lorenzo C, Sandez-Macho I, Concheiro A, Otero-Espinar FJ. Hydrosoluble cyclodextrin/poloxamer polypseudorotaxanes at the air/water interface, in bulk solution, and in the gel state. J Phys Chem B. 2009;113(9):2773-82. 4. Gómez EC, Anguiano Igea S, Gómez Amoza JL, Otero Espinar FJ. Evaluation of the promoting effect of soluble cyclodextrins in drug nail penetration. Eur J Pharma Sci. 2018;117:270-8. 5. Loftsson T, Jarho P, Másson P, Järvinen T. Cyclodextrins in drug delivery. Expert Opin Drug Deliv. 2005;2(2):1-17. 6. Otero-Espinar FJ, Luzardo-Álvarez A, Blanco-Méndez J. Cyclodextrins: More tan pharmaceutical excipients. Mini-reviews in Medicinal Chemistry. 2010;10:715-25. 7. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23(12):2709-28. 8. Nogueiras-Nieto L, Sobarzo-Sánchez E, Gómez-Amoza JL, OteroEspinar FJ. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery. Eur J Pharm Biopharm. 2012;80(3):585-95. 9. Cutrín-G, Anguiano-Igea S, Delgado-Charro MB. Effect on nail structure and transungual permeability of the ethanol and poloxamer ratio from cyclodextrin-soluble polypseudorotaxanes based nail lacquer. Pharmaceutics. 2018;10:156. 10. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) [Internet]. Madrid: Ficha técnica o resumen de las características del producto DexULac 80 mg/g barniz de uñas medicamentoso. [Consultado 13/07/2022]. Disponible en: https://cima.aemps.es/cima/dochtml/ft/84423/FT_84423.html. 11. Gupta AK, Plott T. Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties. Int J Dermatol. 2004;43(Suppl 1):3-8. 12. Fernández-Campos F, Navarro F, Corrales A, Picas J, Pena E, González J, Otero-Espinar FJ. Transungual delivery, anti-inflammatory activity, and in vivo assessment of a cyclodextrin polypseudorotaxanes nail lacquer. Pharmaceutics. 2020;12(8):730.
RkJQdWJsaXNoZXIy MTAyMDQzMg==